Insider · CIK 0001185858

BALTIMORE DAVID

Reports to the SEC for 4 companies · THOUSAND OAKS, CA

sec.gov

Transactions

Companies

Filings

CIK

0001185858

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.U Disposition from Tender	Director	UDisposition from Tender	−5,208 sh	—	—	57,292
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−60K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−9,000 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−4,000 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−9,000 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−2,325 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−57.3K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−60K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−57.3K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−4,000 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−4,650 sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.Stock OptionD Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2025-06-25	Regulus Therapeutics Inc.U Disposition from Tender	Director	UDisposition from Tender	−27.4K sh	—	—	57,292
2025-04-30	Regulus Therapeutics Inc.A Award	Director	AAward	+62.5K sh	—	—	84,669
2025-04-30	Regulus Therapeutics Inc.A Award	Director	AAward	+62.5K sh	—	—	62,500
2025-01-30	Regulus Therapeutics Inc.P Purchase	Director	PPurchase	+19.6K sh	$1.06	+$20.8K	22,169
2024-05-20	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+60K sh	—	—	60,000
2024-05-16	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2023-08-10	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2023-06-13	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2022-06-09	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+90K sh	—	—	90,000
2021-06-14	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+40K sh	—	—	40,000
2020-06-17	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+23.3K sh	—	—	23,250
2019-10-10	Regulus Therapeutics Inc.Stock Option (Right to Buy)A Award	Director	AAward	+46.5K sh	—	—	46,500
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,281 sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,058 sh	—	—	0
2019-04-02	IMMUNE DESIGN CORP.D Disposition to Issuer	Director	DDisposition to Issuer	−78.3K sh	$5.85	−$458K	0
2019-04-02	IMMUNE DESIGN CORP.Stock Option (Rt to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.5K sh	—	—	0
2019-01-03	IMMUNE DESIGN CORP.Stock Option (right to buy)A Award	Director	AAward	+12.5K sh	—	—	12,500
2018-11-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,051 sh	—	—	0
2018-11-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,458 sh	—	—	0
2018-11-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−416 sh	—	—	0
2018-11-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,458 sh	—	—	0
2018-11-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−416 sh	—	—	0
2018-11-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,458 sh	—	—	0
2018-11-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2018-11-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−625 sh	—	—	0
2018-11-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,458 sh	—	—	0
2018-11-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,458 sh	—	—	0
2018-11-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−625 sh	—	—	0
2018-11-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,458 sh	—	—	0
2018-11-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−6,250 sh	—	—	0
2018-11-12	Regulus Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−625 sh	—	—	0

Recent filings

Accepted (ET)
Jun 274
BALTIMORE DAVID0000950170-25-091008
SEC(opens sec.gov)
Apr 304
BALTIMORE DAVID0000950170-25-061118
SEC(opens sec.gov)

Companies

Address

ONE AMGEN CENTER DRIVE

THOUSAND OAKS, CA, 91320-1799